116 related articles for article (PubMed ID: 11489506)
1. The effects of subcellular localization of N-(2-hydroxypropyl)methacrylamide copolymer-Mce(6) conjugates in a human ovarian carcinoma.
Tijerina M; Kopecková P; Kopecek J
J Control Release; 2001 Jul; 74(1-3):269-73. PubMed ID: 11489506
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
Tijerina M; Kopecková P; Kopecek J
Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
[TBL] [Abstract][Full Text] [Related]
3. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.
Tijerina M; Kopecková P; Kopecek J
Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627
[TBL] [Abstract][Full Text] [Related]
4. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
Shiah JJ; Sun Y; Peterson CM; Kopecek J
J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
[TBL] [Abstract][Full Text] [Related]
7. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
Omelyanenko V; Gentry C; Kopecková P; Kopecek J
Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of disulfide-linked HPMA copolymer-mesochlorin e6 conjugates.
Cuchelkar V; Kopecková P; Kopecek J
Macromol Biosci; 2008 May; 8(5):375-83. PubMed ID: 18215003
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J
Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
[TBL] [Abstract][Full Text] [Related]
11. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
Tijerina M; Fowers KD; Kopecková P; Kopecek J
Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice.
Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J
Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167
[TBL] [Abstract][Full Text] [Related]
13. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
Kunath K; Kopecková P; Minko T; Kopecek J
Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
[TBL] [Abstract][Full Text] [Related]
14. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
Omelyanenko V; Kopecková P; Gentry C; Kopecek J
J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.
Jensen KD; Nori A; Tijerina M; Kopecková P; Kopecek J
J Control Release; 2003 Feb; 87(1-3):89-105. PubMed ID: 12618026
[TBL] [Abstract][Full Text] [Related]
16. Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells.
Nori A; Jensen KD; Tijerina M; Kopecková P; Kopecek J
J Control Release; 2003 Aug; 91(1-2):53-9. PubMed ID: 12932637
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.
Hongrapipat J; Kopecková P; Prakongpan S; Kopecek J
Int J Pharm; 2008 Mar; 351(1-2):259-70. PubMed ID: 18029122
[TBL] [Abstract][Full Text] [Related]
18. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J
J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655
[TBL] [Abstract][Full Text] [Related]
19. HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer.
Peterson CM; Shiah JG; Sun Y; Kopecková P; Minko T; Straight RC; Kopecek J
Adv Exp Med Biol; 2003; 519():101-23. PubMed ID: 12675211
[TBL] [Abstract][Full Text] [Related]
20. Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
Lu ZR; Kopecková P; Kopecek J
Nat Biotechnol; 1999 Nov; 17(11):1101-4. PubMed ID: 10545917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
